BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Inhixa® (enoxaparin sodium): risk of self-activation of the safety device in unopened, unused pre-filled syringes

Active substance: enoxaparin sodium

The company Techdow Pharma Germany GmbH is circulating information on rare cases of premature self-activation of the safety device in unopened, unused pre-filled Inhixa syringes.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 681KB, File is accessible